/*The following code gives the blog a Grid Pattern with three blog entries per row*/
Methuselah Foundation
  • Home
  • Our Team Our Investments Our Partners
  • Return On Mission About Us Strategies Our Achievements Media Articles Financials
  • Donate The 300 Monument Volunteer
  • NEWS
Methuselah Foundation
  • Home/
  • Who We Are/
    • Our Team
    • Our Investments
    • Our Partners
  • What We Do/
    • Return On Mission
    • About Us
    • Strategies
    • Our Achievements
    • Media Articles
    • Financials
  • Join Us/
    • Donate
    • The 300 Monument
    • Volunteer
  • NEWS/
Methuselah Foundation

Making 90 the new 50 by 2030

NEWS

The latest on Methuselah, health span research, and regenerative medicine

Methuselah Foundation
  • Home/
  • Who We Are/
    • Our Team
    • Our Investments
    • Our Partners
  • What We Do/
    • Return On Mission
    • About Us
    • Strategies
    • Our Achievements
    • Media Articles
    • Financials
  • Join Us/
    • Donate
    • The 300 Monument
    • Volunteer
  • NEWS/
May 03, 2022

Cell rejuvenation trailblazer Turn Bio closes funding round

May 03, 2022/ Methuselah Foundation
Cell rejuvenation trailblazer Turn Bio closes funding round

A few weeks ago, cell rejuvenation company Turn Biotechnologies announced that it had completed an oversubscribed fundraising round. While that is noteworthy, what really caught our attention was the list of organizations participating in the round.

Read More
May 03, 2022/ Methuselah Foundation/
turn bio, pharma, pharmaceuticals, cell age, cells, cell reprogramming, mrna
METHUSELAH FOUNDATION IS A 501(C)(3) ORGANIZATION • 8021 FLINT STREET, SPRINGFIELD, VA 22153 • INFO@MFOUNDATION.ORG • PRIVACY POLICY • © 2020